|
|
Abbott Diagnostics (NYSE: ABT) is a $4B division of Abbott Laboratories, Inc., a global leader in in vitro diagnostics, and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, blood banks, physician offices, and clinics. With more than 69,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, cost effectiveness, and flexibility. The history of Abbott Diagnostics is filled with examples of first-of-a-kind products and significant technological advancements.
Abbott is using Axeda software to enable their service operations to remotely monitor, manage, and service several lines of medical diagnostic instruments including immunoassay systems and hematology analyzers.
-
15% less calls requiring field service
-
Improved instrument uptime and performance
-
Better customer service at lower costs
|
